KMT2A and acute myeloid leukemia: Further in vitro testing revealed inhibitory effects of MBZ on the proliferation and clonogenicity of both MLL-rearranged and non-rearranged human AML cell lines (THP-1, OCI-AML3, NOMO-1, KCL22, U937, MV4-11, KASUMI-1, and SHI-1).